Quarterly report · Q2
3604.TEDINET S100SAC7
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥30.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥100m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥279m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥825m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥289m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥338m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥179m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥747m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥217m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥208m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥222m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥19.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥17.0bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥12.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥866m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥339m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥175m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥62m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥205m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥705m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥122m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥858m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥223m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥30.84 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.47 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.46 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.32 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2023-09-30 | −¥294m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥389m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥512m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2022-09-30 | −¥244m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥449m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥136m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥585m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)神田 正史 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤本 裕人 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 15130485000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 14604317000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 30403907000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 340882000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 218149000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 824906000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 217088000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 178726000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 747405000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 346477000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 302050000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 839635000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6230611000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 7517037000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 7307714000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 17013667000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 19540881000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 19510083000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 37.46 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 30.84 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 128.96 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.362 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.349 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.341 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 61954000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 338558000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 174542000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -122261000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -205478000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -705300000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -222747000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 3581000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 857618000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 865540000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1622918000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1454593000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 24.32 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 23.47 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 6000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 6000000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |